We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-11.00 | -0.65% | 1,694.00 | 1,709.00 | 1,711.00 | 1,720.00 | 1,699.00 | 1,708.00 | 330,122 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 1,155.41 | 2.31B |
By Adriano Marchese
Indivior PLC said Monday that it has agreed to pay Reckitt Benckiser Group PLC $50 million over the next five years after reaching a settlement over their 2014 demerger agreement.
The U.K. pharmaceutical company said the two companies settled the claims which Reckitt Benckiser issued in the Commercial Court in London in mid November, seeking indemnity under the demerger agreement between them in 2014.
Reckitt Benckiser has agreed to withdraw the $1.4 billion claim and released Indivior from any claim for indemnity.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 25, 2021 12:58 ET (17:58 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions